4.5 Article

Controversies in Glaucoma: Current Medical Treatment and Drug Development

Journal

CURRENT PHARMACEUTICAL DESIGN
Volume 21, Issue 32, Pages 4673-4681

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612821666150909095553

Keywords

Glaucoma; intraocular pressure; IOP lowering drugs; drug development

Ask authors/readers for more resources

Elevated eye pressure is the main risk factor for glaucoma; intraocular pressure rises when the ratio between aqueous humor formation (inflow) and its outflow is unbalanced. Currently, the main goal of medical treatment is the reduction of intraocular pressure. Five main classes of topical drugs are available; they include betablockers, carbonic anhydrase inhibitors, prostaglandin derivatives, sympathomimetics and miotics. Beta-blockers and carbonic anhydrase inhibitors slow the formation of aqueous humor and may be considered as inflow drugs; the other three classes reduce the resistance to the drainage of aqueous humor and may be considered as outflow drugs. Despite the variety of drugs accessible in the market, there is a real need for ophthalmologists to have more potent medications for this disease. This review focuses on medical treatment of glaucoma with particular attention to novel molecules in pre-clinical or clinical development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Caffeine Protects Against Retinal Inflammation

Federica Conti, Francesca Lazzara, Giovanni Luca Romano, Chiara Bianca Maria Platania, Filippo Drago, Claudio Bucolo

Summary: Caffeine can alleviate retinal inflammation, restore retinal cell barrier function, and maintain normal levels of brain-derived neurotrophic factor (BDNF) in the retina. These findings suggest that caffeine is a good candidate for combating inflammation in retinal diseases.

FRONTIERS IN PHARMACOLOGY (2022)

Article Ophthalmology

OCT-angiography follow-up of choroidal neovascularization treated with treat- and- extend aflibercept regimen to avoid over-treatment

Claudio Furino, Valeria Albano, Michela Mangione, Roberta Galati, Maria D'Addario, Michele Reibaldi, Francesco Boscia, Giovanni Alessio

Summary: This pilot study explores the use of optical coherence tomography angiography (OCT-A) in evaluating the dry macula of neovascular age-related macular degeneration (nAMD) treated with a treat-and-extend (T&E) aflibercept regimen. The study suggests that OCT-A may be useful in determining the optimal approach for adjusting injection intervals based on changes in CNV size.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2023)

Article Microbiology

Characterization and Comparison of Ocular Surface Microbiome in Newborns

Francesco Petrillo, Arianna Petrillo, Maddalena Marrapodi, Carlo Capristo, Maria Francesca Gicchino, Paolo Montaldo, Elisabetta Caredda, Michele Reibaldi, Lara M. Boatti, Federica Dell'Annunziata, Veronica Folliero, Marilena Galdiero

Summary: The ocular microbiome plays a crucial role in maintaining immune eye homeostasis, and its composition can be altered by antibiotic prophylaxis.

MICROORGANISMS (2022)

Article Ophthalmology

Primary small gauge pars plana vitrectomy and silicone oil endotamponade for endophthalmitis after cataract surgery: Clinical and OCT findings

Tito Fiore, Marco Lupidi, Alessio Cerquaglia, Fabrizio Giansanti, Michele Reibaldi, Barbara Iaccheri, Davide Tucci, Marco Messina, Carlo Cagini

Summary: Retrospective analysis shows that OCT changes after acute postoperative endophthalmitis can be persistent or self-resolving, and seem to be related to the progression of infection/inflammation from the vitreous cavity to the inner and outer retina, rather than to the surgery.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2023)

Article Plant Sciences

Carnosol attenuates high glucose damage in human retinal endothelial cells through regulation of ERK/Nrf2/HO-1 pathway

Velia D'Agata, Agata Grazia D'Amico, Grazia Maugeri, Claudio Bucolo, Settimio Rossi, Salvatore Giunta

Summary: This study found that carnosol can protect retinal vascular endothelium from the damage caused by high glucose by activating the Nrf2/HO-1 signaling pathway. This suggests that carnosol may be a valuable drug for the treatment of diabetic retinopathy.

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2023)

Article Biochemistry & Molecular Biology

Heme Oxygenase-1 Overexpression Promotes Uveal Melanoma Progression and Is Associated with Poor Clinical Outcomes

Lucia Longhitano, Giuseppe Broggi, Sebastiano Giallongo, Maria Failla, Lidia Puzzo, Teresio Avitabile, Daniele Tibullo, Alfio Distefano, Valeria Pittala, Michele Reibaldi, Guido Nicola Zanghi, Antonio Longo, Andrea Russo, Rosario Caltabiano, Giovanni Li Volti, Nicolo Musso

Summary: The study revealed the important role of HO-1 in regulating uveal melanoma progression, with an increase of HO-1 promoting cellular proliferation and wound healing ability of tumor cells, suggesting HO-1 protein expression may serve as a potential prognostic and therapeutic factor in UM patients.

ANTIOXIDANTS (2022)

Article Ophthalmology

Dexamethasone intravitreal implant along with femtosecond laser assisted cataract surgery in patients with diabetic macular edema and cataract

Claudio Furino, Alfredo Niro, Michele Reibaldi, Francesco Boscia, Giovanni Alessio

Summary: The safety and efficacy of intraoperative DEX implant in patients with DME undergoing FLACS were assessed. The results showed that DEX implant significantly improved visual acuity and central retinal thickness in these patients.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2023)

Article Medicine, General & Internal

Microvascular Changes after Scleral Buckling for Rhegmatogenous Retinal Detachment: An Optical Coherence Tomography Angiography Study

Matteo Fallico, Antonio Longo, Teresio Avitabile, Pietro Alosi, Marco Grillo, Niccolo Castellino, Vincenza Bonfiglio, Michele Reibaldi, Francesco Pignatelli, Andrea Russo

Summary: This study investigated macular microvascular alterations after successful scleral buckling for rhegmatogenous retinal detachment. The results showed that microvascular changes were present after surgery, but VD impairment seemed to be mitigated postoperatively. A greater increase in postoperative axial length was associated with a poorer VD outcome.

DIAGNOSTICS (2022)

Article Ophthalmology

Visual Outcomes and Optical Coherence Tomography Biomarkers of Vision Improvement in Patients With Leber Hereditary Optic Neuropathy Treated With Idebenone

Enrico Borrelli, Alessandro Berni, Maria Lucia Cascavilla, Costanza Barresi, Marco Battista, Giorgio Lari, Michele Reibaldi, Francesco Bandello, Piero Barboni

Summary: This retrospective study examined the relationship between demographics, clinical characteristics, and structural OCT findings and long-term visual outcomes in patients with LHON treated with idebenone therapy. The results showed that the thickness of GC-IPL in the macula was associated with final BCVA at 2 years in these patients.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2023)

Article Biochemistry & Molecular Biology

The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology

Martina Di Bartolomeo, Tibor Stark, Serena Di Martino, Fabio Arturo Iannotti, Jana Ruda-Kucerova, Giovanni Luca Romano, Martin Kuchar, Samuele Laudani, Petr Palivec, Fabiana Piscitelli, Carsten T. Wotjak, Claudio Bucolo, Filippo Drago, Vincenzo Di Marzo, Claudio D'Addario, Vincenzo Micale

Summary: Adolescent exposure to cannabinoids, such as THC, may increase the risk of psychosis in individuals exposed to perinatal insult. In this study, the researchers examined the effects of peripubertal THC exposure on rats that were also exposed to prenatal methylazoxymethanol acetate (MAM) or perinatal THC (pTHC). They found that the rats exposed to MAM or pTHC exhibited adult phenotypes relevant to schizophrenia, including social withdrawal and cognitive impairment. The researchers also observed changes in gene expression and DNA methylation, suggesting potential molecular mechanisms underlying these effects.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, General & Internal

The Short-Term Results of Autologous Platelet-Rich Plasma as an Adjuvant to Re-Intervention in the Treatment of Refractory Full-Thickness Macular Holes

Matilde Buzzi, Guglielmo Parisi, Paola Marolo, Francesco Gelormini, Mariantonia Ferrara, Raffaele Raimondi, Davide Allegrini, Tommaso Rossi, Michele Reibaldi, Mario R. Romano

Summary: The study aimed to investigate the short-term efficacy and safety of autologous platelet-rich plasma (a-PRP) as an adjuvant treatment for refractory full-thickness macular holes (rFTMHs). A total of 28 eyes from 27 patients with rFTMHs received a-PRP treatment after primary repair. At the six-month follow-up, the overall closure rate was 92.9% and visual acuity significantly improved. No intraoperative or postoperative complications were reported. Therefore, a-PRP can be an effective adjuvant treatment for rFTMHs.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

A Re-Purposing Strategy: Sub-Lethal Concentrations of an Eicosanoid Derived from the Omega-3-Polyunsaturated Fatty Acid Resolvin D1 Affect Dual Species Biofilms

Angela Maione, Annalisa Buonanno, Marilena Galdiero, Elisabetta de Alteriis, Francesco Petrillo, Michele Reibaldi, Marco Guida, Emilia Galdiero

Summary: This study evaluated the antimicrobial effects of Resolvin D1 (RvD1) on Staphylococcus aureus and Candida parapsilosis, as well as its activity against mixed biofilms. The results showed that both the bacteria and fungi were inhibited at minimum concentration values between 5 and 10 mu g mL(-1). Additionally, RvD1 demonstrated eradication capability of 60% and 80% for single- and mixed-species biofilms, respectively. These findings suggest that RvD1 is a promising alternative for the treatment of bacterial/fungal infections.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, General & Internal

Retinal Thickness Deviation: A New OCT Parameter for Assessing Diabetic Macular Edema

Paola Marolo, Enrico Borrelli, Francesco Gelormini, Giacomo Boscia, Guglielmo Parisi, Matteo Fallico, Costanza Barresi, Giorgio Lari, Alessandro Berni, Francesco Bandello, Michele Reibaldi

Summary: This study aims to determine the retinal thickness deviation (RTD) in eyes with diabetic macular edema (DME) treated with intravitreal therapy and establish associations between RTD and best-corrected visual acuity (BCVA). Retrospective analysis was conducted on DME patients undergoing intravitreal therapy. Results showed that RTD had a moderate association with BCVA at different time points and could be used as a reference for visual outcomes in DME eyes treated with intravitreal therapy.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Infectious Diseases

Candida Biofilm Eye Infection: Main Aspects and Advance in Novel Agents as Potential Source of Treatment

Francesco Petrillo, Marica Sinoca, Antonio Maria Fea, Marilena Galdiero, Angela Maione, Emilia Galdiero, Marco Guida, Michele Reibaldi

Summary: Fungi, particularly Candida species, are a significant cause of microbial eye infections, leading to sight-threatening diseases and irreversible vision loss. Diagnosing and treating these infections is challenging, and biofilm formation by Candida makes it a dangerous pathogen. This review provides an overview of the current knowledge on the pathology, diagnosis, and treatment of ocular Candida infections. It also explores the potential of natural compounds, such as nanoparticles and nanocarriers, as drug delivery systems, and discusses the effectiveness of drug combinations in combating difficult-to-treat Candida infections.

ANTIBIOTICS-BASEL (2023)

Article Chemistry, Medicinal

Drug-Repurposing Strategy for Dimethyl Fumarate

Salvatore Giunta, Agata Grazia D'Amico, Grazia Maugeri, Claudio Bucolo, Giovanni Luca Romano, Settimio Rossi, Chiara M. Eandi, Elisabetta Pricoco, Velia D'Agata

Summary: In the area of drug discovery, repurposing strategies are used to discover new uses of approved drugs. In this study, the effects of DMF on early injury associated with diabetic retinopathy were investigated. The results showed that DMF can counteract the inflammatory process and the oxidative response in diabetic retinopathy.

PHARMACEUTICALS (2023)

No Data Available